The sponsor reviewed the manuscript before
it was submitted for publication but did not control
the interpretation of the results or the decision
to submit the manuscript for publication.
The study was designed by the planning committee
and executive committee, the participating investigators
collected the data, and all the authors
wrote the manuscript. The executive committee
made the decision to submit the manuscript for
publication. The coordinating center had full access
to the data and vouches for the accuracy
and completeness of the data and analysis. The
executive committee and the coordinating center
vouch for the fidelity of the study to the protocol.
Merck donated losartan and lisinopril for the
study but was not involved in the study design,
data analysis, or manuscript preparation.